119 related articles for article (PubMed ID: 9076236)
1. p53 protein expression in benign lesions of the upper respiratory tract.
Ingle RR; Setzen G; Koltai PJ; Monte D; Pastore J; Jennings TA
Arch Otolaryngol Head Neck Surg; 1997 Mar; 123(3):297-300. PubMed ID: 9076236
[TBL] [Abstract][Full Text] [Related]
2. [Expression of P53 protein in laryngeal carcinoma and its clinical significance].
Wang D; Yi Z; Yang F
Zhonghua Er Bi Yan Hou Ke Za Zhi; 1995; 30(6):354-6. PubMed ID: 8762527
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of human papillomavirus, Epstein-Barr virus, p21, and p53 expression in sinonasal inverted papilloma, nasal polyp, and hypertrophied turbinate in Hong Kong patients.
Sham CL; To KF; Chan PK; Lee DL; Tong MC; van Hasselt CA
Head Neck; 2012 Apr; 34(4):520-33. PubMed ID: 21608063
[TBL] [Abstract][Full Text] [Related]
4. Immunohistochemical analysis of PCNA, Ki67 and p53 in nasal polyposis and sinonasal inverted papillomas.
Mumbuc S; Karakok M; Baglam T; Karatas E; Durucu C; Kibar Y
J Int Med Res; 2007; 35(2):237-41. PubMed ID: 17542411
[TBL] [Abstract][Full Text] [Related]
5. Do nasal polyps and inverted papilloma have similar disorders in cell cycle regulation?
Robinson S; Tan LW; James C; Karakousis A; Wormald PJ
Am J Rhinol; 2006; 20(6):637-40. PubMed ID: 17181109
[TBL] [Abstract][Full Text] [Related]
6. Inverted urothelial papilloma: is ploidy, MIB-1 proliferative activity, or p53 protein accumulation predictive of urothelial carcinoma?
Cheville JC; Wu K; Sebo TJ; Cheng L; Riehle D; Lohse CM; Shane V
Cancer; 2000 Feb; 88(3):632-6. PubMed ID: 10649258
[TBL] [Abstract][Full Text] [Related]
7. Human papillomavirus type, proliferative activity, and p53: potential markers of aggressive papillomatosis.
Rabah R; Sakr W; Thomas R; Lancaster WD; Gregoire L
Arch Pathol Lab Med; 2000 May; 124(5):721-4. PubMed ID: 10782155
[TBL] [Abstract][Full Text] [Related]
8. p53 protein overexpression in laryngeal squamous cell papillomas.
Poljak M; Gale N; Kambic V; Luzar B
Anticancer Res; 1997; 17(3C):2201-5. PubMed ID: 9216688
[TBL] [Abstract][Full Text] [Related]
9. 14-3-3 gene expression exerts isoform-dependent functions in sinonasal pathophysiology.
Kataki A; Alevizos L; Lazaris A; Glustianou G; Derventzi A; Giotakis E; Konstadoulakis M; Yiotakis I
Pathol Res Pract; 2014 Feb; 210(2):105-10. PubMed ID: 24268498
[TBL] [Abstract][Full Text] [Related]
10. Expression of p53 in inverted papilloma and malignancy associated with inverted papilloma.
Gujrathi C; Pathak I; Freeman J; Asa S
J Otolaryngol; 2003 Feb; 32(1):48-50. PubMed ID: 12779261
[TBL] [Abstract][Full Text] [Related]
11. Expression of the the cyclin-kinase inhibitors p21(WAF1) and p27(Kip1) and the p53 tumor suppressor genes in adult-onset laryngeal papillomas.
Erdamar B; Keles N; Kaur A; Suoglu Y; Kiyak E
Eur Arch Otorhinolaryngol; 2002 Nov; 259(10):516-20. PubMed ID: 12434183
[TBL] [Abstract][Full Text] [Related]
12. Detection of human papillomavirus and relevant tumor suppressors and oncoproteins in laryngeal tumors.
Manjarrez ME; Ocadiz R; Valle L; Pacheco C; Marroquin A; De la Torre C; Selman M; Gariglio P
Clin Cancer Res; 2006 Dec; 12(23):6946-51. PubMed ID: 17145812
[TBL] [Abstract][Full Text] [Related]
13. [Study on the association between HPV16/18 and expression of p53 protein in laryngeal papillomas].
Chu HQ; Reyt E
Lin Chuang Er Bi Yan Hou Ke Za Zhi; 2000 Jun; 14(6):271-2. PubMed ID: 12541538
[TBL] [Abstract][Full Text] [Related]
14. Molecular transformation of recurrent respiratory papillomatosis: viral typing and p53 overexpression.
Go C; Schwartz MR; Donovan DT
Ann Otol Rhinol Laryngol; 2003 Apr; 112(4):298-302. PubMed ID: 12731623
[TBL] [Abstract][Full Text] [Related]
15. Immunohistochemical expression of metallothionein in benign premalignant and malignant epithelium of the larynx: correlation with p53 and proliferative cell nuclear antigen.
Ioachim E; Assimakopoulos D; Peschos D; Zissi A; Skevas A; Agnantis NJ
Pathol Res Pract; 1999; 195(12):809-14. PubMed ID: 10631715
[TBL] [Abstract][Full Text] [Related]
16. [Immunohistochemical study of p53 and Ki-67 in inverted papillomas and nasal polyps arising from nasal or paranasal regions].
Ikegawa K; Matsukuma S
Rinsho Byori; 2005 Jun; 53(6):499-503. PubMed ID: 16026075
[TBL] [Abstract][Full Text] [Related]
17. Association between HPV 16/18 infection and expression of P53 protein in laryngeal papillomas.
Chu H; Reyt E
J Tongji Med Univ; 1999; 19(4):275-6. PubMed ID: 12938516
[TBL] [Abstract][Full Text] [Related]
18. [Prevalence of papillomavirus infection among patients with laryngeal papillomatosis and the effects of some risk factors on the persistence of papillomaviruses in the upper respiratory tract].
Velyvyte D; Laiskonis A; Uloza V; Gozdzicka-Jozefiak A
Medicina (Kaunas); 2002; 38(5):499-504. PubMed ID: 12474680
[TBL] [Abstract][Full Text] [Related]
19. Malignant transformation of recurrent respiratory papillomatosis associated with integrated human papillomavirus type 11 DNA and mutation of p53.
Rady PL; Schnadig VJ; Weiss RL; Hughes TK; Tyring SK
Laryngoscope; 1998 May; 108(5):735-40. PubMed ID: 9591556
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of p53 protein in benign and malignant laryngeal epithelial lesions.
Poljak M; Gale N; Kambic V; Ferluga D; Fischinger J
Anticancer Res; 1996; 16(4A):1947-51. PubMed ID: 8712726
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
